Axq Capital, LP Natera, Inc. Transaction History

Axq Capital, LP

$428 Billion
Q2 2024

A detailed history of Axq Capital, LP transactions in Natera, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 7,566 shares of NTRA stock, worth $957,023. This represents 0.19% of its overall portfolio holdings.

Number of Shares

7,566

Holding current value

$957,023

% of portfolio

0.19%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	$85.28 - $112.6 $645,228 - $851,931	7,566 New	7,566 $819 Million
Q4 2023 Feb 13, 2024	BUY	$37.55 - $62.64 $172,730 - $288,144	4,600 New	4,600 $288 Million

Others Institutions Holding NTRA

# of Institutions

504

Shares Held

120M

Call Options Held

412K

Put Options Held

270K

Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$1.43 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

6.77M
Shares

$857 Million
0.02% of portfolio
Jpmorgan Chase & CO New York, NY

6.07M
Shares

$767 Million
0.06% of portfolio
Fred Alger Management, LLC New York, NY

5.26M
Shares

$666 Million
2.83% of portfolio
Farallon Capital Management LLC San Francisco, CA

4.46M
Shares

$564 Million
2.34% of portfolio

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $12.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Account